Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Payers’ Use Of Real-World Evidence For Drug Coverage On The Rise – IMS Health

Executive Summary

A new study by IMS Health shows payers globally are making more drug reimbursement decisions based on real-world evidence – including 25% of more than 100 identified case studies using biopharma industry-generated data.

Advertisement

Related Content

Getting Results From Big Data Depends On Trust Between Stakeholders
Big Data Transforming The Role Of Pharma, IBM Analytics Partner Says
Swedish Real World COPD Pneumonia Analysis Backs Symbicort Over Seretide
Drug Development Needs “Clean-Slate Think” To Involve Patients All Along The Way – Pfizer’s Lewis-Hall
AZ, IMS To Build Disparate Data Sets Into Broader Outcomes Consensus
Pharma/Payor Deals An Important Step In The Shift To Value-Based R&D
Private Sector Will Be Key Source Of Data To Inform Value-Based Coverage Decisions – Former Merck Exec Spatz
WellPoint CE Study Results In Coverage Adjustment For Oral Asthma Drugs
Merck Bolsters Januvia Access With Outcomes-Based Discounts To CIGNA

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS055373

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel